Background Oncofetal protein high-mobility-group AT-hook protein 2 (HMGA2) is reactivated in serous ovarian cancer (SOC) and its overexpression correlates with poor prognosis. To explore the mechanism, we investigated whether HMGA2 could avoid microRNA regulation due to gene truncation or 3' UTR shortening by alternative polyadenylation. Methods Real-time reverse transcription polymerase chain reaction (RT-PCR) was used to evaluate the abundance of different regions of HMGA2 mRNA in 46 SOC samples. Rapid amplification of cDNA 3' ends (3' RACE) and Southern blotting were used to confirm the shortening of 3' untranslated region (UTR). 5' RACE and Southern blotting were used to prove the mRNA decay. Results No si...
The state of chromatin in human embryonic stem cells (hESCs) is a key factor determining stem cell i...
The high-mobility group Hmga family of proteins are non-histone chromatin-interacting proteins which...
Chromosomal rearrangements of the HMGA2 locus belong to the most common aberrations in human benign ...
To examine the expression of high mobility group A2 (HMGA2), P53 and let-7 family microRNA, to inves...
The high mobility group AT-hook 2 (HMGA2) gene is expressed during embryogenesis but silenced in adu...
The high-mobility group AT-hook 2 (HMGA2) protein is a member of the high-mobility group family of t...
BACKGROUND: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typicall...
AbstractObjectiveTo analyze effects of high mobility group AT-hook 2 (HMGA2) on malignant degree, in...
The high-mobility group A protein 2 (HMGA2) is a non-histone chromatin factor highly expressed in fe...
Background: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typicall...
Despite improved therapeutic strategies for early-stage breast cancer, the most common cancer type i...
Background The HMGA2 gene, coding for an architectural transcription factor involved...
The high mobility group protein 2 (HMGA2) regulates gene expression by binding to ATrich regions of ...
High Motility Group A-T hook 2 (HMGA2) is a transcriptional regulator that binds to short AT rich se...
Ovarian cancer is the most lethal gynecological malignancy and the high mortality rate is associated...
The state of chromatin in human embryonic stem cells (hESCs) is a key factor determining stem cell i...
The high-mobility group Hmga family of proteins are non-histone chromatin-interacting proteins which...
Chromosomal rearrangements of the HMGA2 locus belong to the most common aberrations in human benign ...
To examine the expression of high mobility group A2 (HMGA2), P53 and let-7 family microRNA, to inves...
The high mobility group AT-hook 2 (HMGA2) gene is expressed during embryogenesis but silenced in adu...
The high-mobility group AT-hook 2 (HMGA2) protein is a member of the high-mobility group family of t...
BACKGROUND: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typicall...
AbstractObjectiveTo analyze effects of high mobility group AT-hook 2 (HMGA2) on malignant degree, in...
The high-mobility group A protein 2 (HMGA2) is a non-histone chromatin factor highly expressed in fe...
Background: The HMGA2 gene encodes a protein that alters chromatin structure. Deregulation, typicall...
Despite improved therapeutic strategies for early-stage breast cancer, the most common cancer type i...
Background The HMGA2 gene, coding for an architectural transcription factor involved...
The high mobility group protein 2 (HMGA2) regulates gene expression by binding to ATrich regions of ...
High Motility Group A-T hook 2 (HMGA2) is a transcriptional regulator that binds to short AT rich se...
Ovarian cancer is the most lethal gynecological malignancy and the high mortality rate is associated...
The state of chromatin in human embryonic stem cells (hESCs) is a key factor determining stem cell i...
The high-mobility group Hmga family of proteins are non-histone chromatin-interacting proteins which...
Chromosomal rearrangements of the HMGA2 locus belong to the most common aberrations in human benign ...